Investor Backing & Capital Strength:
Recent funding, including a $10M raise in December 2024, is described as extending runway and supporting product expansion. Feedback suggests this adds resilience to execute on roadmap and go‑to‑market plans.
Product Line Growth:
Launch and continued iteration of Signal, with docs updated through mid‑2025 and onboarding workflows, indicate an active shipping cadence beyond basic record retrieval. Feedback suggests expanding features like real‑time alerts are increasing product depth and utility.
Market Expansion:
Connectivity across Carequality, CommonWell, and eHealth Exchange with steps toward TEFCA participation via CommonWell point to broader national data access. Feedback suggests marketed reach to "320+ million" patients can support commercial adoption across use cases.
